Rostock Prospective Cancer QoL Study

Study summary

A prospective study by Rostock and Naumann in Germany involving 639 cancer patients.

What is commonly claimed

Complementary care in oncology fails to objectively improve the Quality of Life for patients.

What the study actually found

The study observed a statistically significant improvement in the Quality of Life for all 639 cancer patients receiving homeopathic support alongside traditional care.

Key findings

• Significant improvement in global Quality of Life.
• Positive outcomes across a large oncological cohort.
• Safe and non-toxic integration with hospital protocols.